Daniela Monti obtained Ph.D. in “Design, development and bio-evaluation of drugs” in 1993. She continued her work in technological and biopharmaceutical field. She was senior researcher in European project BIOMED-2, (BMH4-97-2324) “Evaluation of oculotoxicity of drugs in vitro”. In 2000, she became Assistant Professor of Pharmaceutical Technology at the Department of Pharmacy, University of Pisa. Currently, she is Associate Professor of Pharmaceutical Technology at the Department of Pharmacy, University of Pisa. Her main research interests are drug delivery (cutaneous, ungual, ophthalmic, vaginal, and buccal), cell cultures (toxicity on corneal epithelium cells), and cosmetic formulations (cutaneous permeation and distribution of cosmetic ingredients). She focused her attention on in vitro and in vivo evaluations of drug delivery systems able to increase ocular bioavailability and promote the permeation and/or accumulation of drugs applied to the skin and nails, as well as in the pilosebaceous apparatus. She has published more than 70 peer-reviewed scientific research articles in high-impact-factor international journals. She is a Scientific Advisor for pharmaceutical companies and a reviewer of several international scientific journals.